Listed

Milestone Scientific Inc.: Form 10-Q for the period ended Sep 30, 2012

Filed with the SEC on Nov 9, 2012 and accepted by EDGAR at Nov 9, 2012, 16:27 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2012-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2012-07-01 to 2012-09-30$2.1mus-gaap:SalesRevenueGoodsNet
Revenue9 months2012-01-01 to 2012-09-30$6.4mus-gaap:SalesRevenueGoodsNet
Cost of revenue3 months2012-07-01 to 2012-09-30$625.7kus-gaap:CostOfGoodsSold
Cost of revenue9 months2012-01-01 to 2012-09-30$2.1mus-gaap:CostOfGoodsSold
Gross profit3 months2012-07-01 to 2012-09-30$1.5mus-gaap:GrossProfit
Gross profit9 months2012-01-01 to 2012-09-30$4.2mus-gaap:GrossProfit
Research and development3 months2012-07-01 to 2012-09-30$60.4kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2012-01-01 to 2012-09-30$139.2kus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2012-07-01 to 2012-09-30$1.4mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2012-01-01 to 2012-09-30$4.3mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2012-07-01 to 2012-09-30$51.6kus-gaap:OperatingIncomeLoss
Operating income9 months2012-01-01 to 2012-09-30−$235.1kus-gaap:OperatingIncomeLoss
Interest expense3 months2012-07-01 to 2012-09-30$36.5kus-gaap:InterestExpense
Interest expense9 months2012-01-01 to 2012-09-30$142.2kus-gaap:InterestExpense
Net income3 months2012-07-01 to 2012-09-30$15.2kus-gaap:NetIncomeLoss
Net income9 months2012-01-01 to 2012-09-30−$504.6kus-gaap:NetIncomeLoss
Diluted shares (weighted)3 months2012-07-01 to 2012-09-3016,369,814 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2012-01-01 to 2012-09-3015,953,925 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2012-01-01 to 2012-09-30$52.8kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2012-01-01 to 2012-09-30$4.1kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2012-09-30$273.5kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2012-09-30$2.8mus-gaap:AssetsCurrent
Total assetsAt period end2012-09-30$5.9mus-gaap:Assets
Current liabilitiesAt period end2012-09-30$3.5mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2012-09-30$2.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-12-463395. Last ingested by Listed: Nov 14, 2026, 11:14 ET. Listed shows no prices and gives no investment advice.